IOR Institute of Oncology Research

Therapeutic Approaches: Biologics, Small Molecules, Biomarkers, Stem Cells, Drug Delivery

Therapeutic Areas of Expertise: Oncology

Center/Program Highlights: The lOR Institute of Oncology Research is part of the Research Division of the Oncology Institute of Southern Switzerland (IOSI), the comprehensive cancer center of the Ente Ospedaliero Cantonale (EOC), and is the main facility for basic and translational research at the IOSI. The Institute was established in 2003 formerly as the IOSI Laboratory of Experimental Oncology.

The Institute comprises different groups working in the areas of tumor biology, genomics, molecular oncology and experimental therapeutics. The expertise available in the Institute spans from cell and molecular biology to molecular pharmacology, genomics and bioinformatics.


IOR serves also as a training facility for Swiss and international undergraduate and graduate students, post-doctoral and clinical fellows in collaboration with Swiss and Italian Universities.


The Institute is an integral component of the clinical research activities of the IOSI participating in translational studies and multi-center clinical trials and providing expertise, facilities and technical support for pharmacodynamics, pharmacogenomics and molecular follow-up studies.

Sources of Funding: Federal/State, Philanthropy, Industry Partnerships

Website

Institutional Affiliation(s):

Address:
via Vela 6
Bellinzona
TI, 6500
Switzerland

Center/Program Start Date: 2003

Number of Employees: 50